BALTIMORE (Stockpickr) -- It's cold on Wall Street this month, both literally and figuratively. Lows are reaching single digits in the Northeast as I write today, but the S&P 500 is positively sub-zero three full weeks into 2014.
>>5 Shareholder Yield Winners to Beat the S&P 500
At last count, the big index is down around 0.24%. Even though equities aren't quite hemorrhaging points this winter, they are giving investors the cold shoulder. And that's precisely why it makes sense to focus on strength as we head into the final trading week of January.
To do that, we're turning to the charts to take a closer look at the technical trading setups in five of Wall Street's biggest names.
If you're new to technical analysis, here's the executive summary.
Technicals are a study of the market itself. Since the market is ultimately the only mechanism that determines a stock's price, technical analysis is a valuable tool even in the roughest of trading conditions. Technical charts are used every day by proprietary trading floors, Wall Street's biggest financial firms, and individual investors to get an edge on the market. And research shows that skilled technical traders can bank gains as much as 90% of the time.
Best India Companies To Invest In 2015: Global X China Energy ETF (CHIE)
Global X China Energy ETF (the Fund) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the S-BOX China Energy Index (the Underlying Index). The Underlying Index is a free float adjusted, liquidity tested and market capitalization-weighted index that is designed to measure performance of the investable universe of companies in the Energy sector of the Chinese economy, as defined by Structured Solutions AG. Global X Management Company, LLC serves as the investment adviser to the Fund. Advisors' Opinion:- [By pamatlarge]
Investors looking to short a particular sector can choose from several Global X long ETFs. The Global X China Consumer ETF (CHIQ) concentrates its investments in consumer cyclical goods and consumer defense goods. The Global X China Energy ETF (CHIE) primarily holds stocks in coal, oil and utility companies. The Global X China Financials ETF (CHIX) only invests in financial services companies and real estate companies. The Global X China Industrials ETF (CHII) holds stocks in industrial companies and basic materials companies. The Global X China Materials ETF (CHIM) invests in basic materials stocks. The Global X China Technology ETF (CHIB) holds technology stocks as the core of its investments. All of these ETFs are particularly sensitive to sector downturns and general economic contractions.
Top 5 Integrated Utility Companies To Watch In Right Now: State Auto Financial Corporation(STFC)
State Auto Financial Corporation, through its subsidiaries, writes personal and business lines of insurance to individuals and small-to-medium sized businesses. The company operates through four segments: Personal insurance, Business insurance, Specialty insurance, and Investment operations. The Personal insurance segment provides personal automobile and homeowners insurance products to the personal insurance market. The Business insurance segment offers commercial automobile, commercial multi-peril, fire and allied lines, and general liability insurance covering small-to-medium sized commercial exposures in the business insurance market. The Specialty insurance segment provides commercial coverages requiring specialized product underwriting, workers? compensation, claims handling, or risk management services. The Investment operations segment offers investment portfolio management services. State Auto Financial Corporation markets its insurance products primarily through independent insurance agencies, which include retail agencies and wholesale brokers in 50 states and the District of Columbia. The company was founded in 1950 and is headquartered in Columbus, Ohio. State Auto Financial Corporation is a subsidiary of State Automobile Mutual Insurance Company.
Advisors' Opinion:- [By CRWE]
State Auto Financial Corporation (Nasdaq:STFC), a super regional property and casualty insurance holding company, will discuss its third quarter 2012 results in a conference call on Tuesday, Nov. 6, 2012, at 10 a.m. ET.
Top 5 Integrated Utility Companies To Watch In Right Now: Appliance Recycling Centers of America Inc.(ARCI)
Appliance Recycling Centers of America, Inc., together with its subsidiaries, sells new household appliances through a chain of its factory outlet stores under the name ApplianceSmart. Its stores offer new special-buy appliances, including prior-year models, close-outs, factory overruns, and scratch-and-dent units, as well as byproduct materials, such as metals of recycled appliances. As of April 2, 2011, the company operated 19 factory outlet stores in Georgia, Minnesota, Ohio, and Texas. The company also provides turnkey appliance recycling and replacement services for electric utilities and other sponsors of energy efficiency programs. It operated 10 processing and recycling centers in California, Colorado, Illinois, Minnesota, North Carolina, Ohio, Pennsylvania, Texas, and Washington; and Ontario, Canada. In addition, the company has a joint venture agreement with ARCA Advanced Processing, LLC, which recycles appliances in the northeastern United States for General Ele ctric Company. The company was founded in 1976 and is based in Minneapolis, Minnesota.
Advisors' Opinion:- [By Lisa Levin]
Appliances: This industry fell 1.07% by 10:35 am ET. Appliance Recycling Centers of America (NASDAQ: ARCI) shares dropped 1.3% in today's trading. Appliance Recycling Centers of America's trailing-twelve-month profit margin is 3.11%.
Top 5 Integrated Utility Companies To Watch In Right Now: Agios Pharmaceuticals Inc (AGIO)
Agios Pharmaceuticals, Inc., incorporated on August 7, 2007, is a biopharmaceutical company. The Company is intend to apply its deep understanding of metabolism, coupled with the Company�� ability to create medicines that can inhibit or activate metabolic enzymes, to fundamentally change the way cancer and inborn errors of metabolism (IEMs) are treated. The Company has identified and validated novel and druggable targets in both cancer and IEMs. The Company�� two advanced cancer programs are targeting mutations in the enzymes isocitrate dehydrogenase 1 and 2, referred to as IDH1 and IDH2. The Company�� drug candidates are selective for the mutated forms of IDH1 and IDH2 found in cancer cells versus the normal forms of IDH1 and IDH2 found in all other cells.
The Company focused on developing medicines to address IEMs, with a novel approach to these orphan diseases for which no effective or disease-modifying therapy is available. The Company has also de-validated and terminated numerous programs, including many that have been reported in scientific journals. In the Company�� IEM portfolio, it uses an equally rigorous set of validation techniques.
Advisors' Opinion:- [By Roberto Pedone]
Another stock that insiders are moving into here is Agios Pharmaceuticals (AGIO), which focuses on the development and commercialization of therapeutics in the field of cancer metabolism and inborn errors of metabolism in the U.S. Insiders are buying this stock into major strength, since shares are up big so far in 2014 by 79%.
Agios Pharmaceuticals has a market cap of $1.4 billion and an enterprise value of $1.5 billion. This stock trades at a premium valuation, with a price-to-sales of 53.91 and a price-to-book of 11.51. Its estimated growth rate for this year is 48.1%, and for next year it's pegged at 15%. This is a cash-rich company, since the total cash position on its balance sheet is $162.27 million and its total debt is zero.
A director just bought 2,300 shares, or about $100,000 worth of stock, at $43.98 per share.
From a technical perspective, AGIO is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock has been selling off after a failed breakout attempt for the last few weeks, with shares moving lower from its high of $50.37 to its intraday low of $42.15 a share. That move is quickly pushing shares of AGIO within range of tagging its 50-day moving average of $40.27 a share.
If you're bullish on AGIO, then I would look for long-biased trades as long as this stock is trending above its 50-day at $40.27 and then once it breaks out above some near-term overhead resistance at $45 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 419,691 shares. If that breakout starts soon, then AGIO will set up to re-test or possibly take out its next major overhead resistance level at its all-time high of $50.37 a share. Any high-volume move above that level will then give AGIO a chance to tag $55 to $60 a share.
- [By Jake L'Ecuyer]
Equities Trading UP
Sangamo Biosciences (NASDAQ: SGMO) shot up 16.32 percent to $22.81 announced the publication in the NEJM of the first-in-man study of genome editing using its ZFN technology. Shares of Agios Pharmaceuticals (NASDAQ: AGIO) got a boost, shooting up 27.72 percent to $40.41 after the company reported quarterly results. BJ's (NASDAQ: BJRI) was also up, gaining 21.04 percent to $33.48 after the company was upgraded toa Buy rating at Buckingham research. - [By Lisa Levin]
Agios Pharmaceuticals (NASDAQ: AGIO) shares touched a new 52-week low of $18.83. Agios Pharmaceuticals' trailing-twelve-month profit margin is -102.87%.
- [By Ben Levisohn]
3. We see 23+ partnered pipeline assets and are most positive on Phase I/II MOR202 anti-CD38 for myeloma with data in 2015, and others such as Acceleron Pharma (XLRN), Agios Pharmaceuticals (AGIO), Epizyme (EPZM), Concert Pharmaceuticals (CNCE) (just started Phase I for next-gen Revlimid).
No comments:
Post a Comment